Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation
In 2015, liposomal formulation of irinotecan (ONIVYDE) has been approved by FDA and widely applied in the treatment of pancreatic cancer. ONIVYDE is a novel liposome formulation, entrapping CPT-11 in the aqueous core of vesicles using a modified gradient loading method. Due to toxicity concerns, it...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
KeAi Communications Co., Ltd.
2019-11-01
|
| Seria: | Asian Journal of Pharmaceutical Sciences |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S1818087618302630 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|